cover
Article Per Year (5 Year)
All
Home Page
OAI Link
Editorial Team
Contact
Reviewer
Google Scholar
Contact Name
Agus Prima
Contact Email
chairman@jsocmed.org
Phone
+6281269200232
Journal Mail Official
chairman@jsocmed.org
Editorial Address
Jl. DR. Wahidin Sudiro Husodo No.243B, Kembangan, Klangonan, Kec. Kebomas, Kabupaten Gresik, Jawa Timur 61124
Location
Kab. gresik,
Jawa timur
INDONESIA
The Journal of Society Medicine (JSOCMED)
Published by PT. CoinReads Media Prima
ISSN : -     EISSN : 29645565     DOI : https://doi.org/10.47353/jsocmed.v2i1
Core Subject : Health, Science,
Health Professions Immunology & microbiology Medicine & Pharmacology Neuroscience
The Journal of Society Medicine (JSOCMED) | ISSN (e): 2964-5565 is a leading voice in the Indonesia and internationally for medicine and healthcare. Published continuously, JSOCMED features scholarly comment and clinical research. JSOCMED is editorially independent from and its The Editor-in-Chief (EIC) is Prof. dr. Aznan Lelo, PhD, SpFK. JSOCMED offers many attractive features for authors, including free online access to all research articles, online publication ahead of print, and online responses to articles published as Quick Comments. In addition, as befitting a publication of the Journal of Society Medicine, JSOCMED implements best practice in scientific publishing with an open peer review process, declarations of competing interests and funding, full requirements for patient consent and ethical review, and statements of guarantorship, contributorship, and provenance.
Arjuna Subject : Kedokteran - Kedokteran (Lain-Lain)
Articles 5 Documents
 1 
Search results for , issue "Vol. 3 No. 6 (2024): June" : 5 Documents clear
Performed Laparoscopic Surgery For Gastric Perforation: Case Report Mirton; Pasihulilzan; Ashan, Hesty Rhauda
Journal of Society Medicine Vol. 3 No. 6 (2024): June
Publisher : CoinReads Media Prima

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.47353/jsocmed.v3i6.147

Abstract

Introduction: Perforated peptic ulcer (PPU) is a life-threatening disease with historically reported high morbidity and mortality rates. The epidemiology of perforated peptic ulcer was appear to be stable in recent. The laparoscopy as primary operation has focused on safety to tread PPU. Case: A 75 years old man presented to our emergency center with generalized abdominal pain since 2 days before admision. Generalize abdominal pain develop suddenly and severe. Patient has history taking NSAID for 7 years to treat pain in the knee joint. He was complaining of chronic and recurrent upper abdominal for 5 year and relieved by food or antacids. He is smoker. After initial resuscitation by adequate administration intravenous lines of fluid and nasogastric tube, Patient underwent a laparocopik surgery, we perform prymari suture and a Graham patch.  We followed administration antibiotic and proton pump inhibitor. We perform the suturing to close the perforation site before peritoneal irrigation to avoid the accumulation of infected fluid and other debris. Once irrigation was complete, a large volume of omentum was reinforced above the primary suture site. Conclusion: We successfully managed perforated peptic ulcers with minimally invasive approach. Adequate resuscitation, hypotension in no longer be a significant prognostic indicator. In experienced hand laparoscopic is probably the most appropriate approach for perforated peptic ulcer. Because no upper abdominal incision is made, there I decreased post operative pain and decrease administration of post operative pain medication. The patient rapidly recovers with less complication.
Rosuvastatin Plus N Acetylcysteine to Prevention of Contrast Induced Acute Kidney Injury in Patients with Low Mehran Risk Score Habib, Mohammed
Journal of Society Medicine Vol. 3 No. 6 (2024): June
Publisher : CoinReads Media Prima

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.47353/jsocmed.v3i6.148

Abstract

Introduction: Contrast induced acute renal injury is the third leading cause of hospital-acquired acute kidney injury, several protective treatments options have been developed among patients undergoing percutaneous coronary intervention (PCI). Our trial aimed to comparison between high dose rosuvastatin versus rosuvastatin plus N acetylcysteine to prevention of contrast induced acute kidney injury in patients undergoing elective PCI at Alshifa hospital in Gaza. Methods: Randomize control trial included 100 patients who undergoing elective PCI at Alshifa Hospital in Gaza, Group A (50 patients) patients received 40 mg rosuvastatin orally once daily for 3 days, on dose before undergoing PCI and two dose after PCI. Group B (50 patients) patients received 40 mg rosuvastatin orally once daily for 3 days, on dose before PCI and two dose after PCI plus N-acetylcysteine 1200 mg orally twice daily every 12 hours for two days, the first dose before PCI and other 3 doses after PCI. All patients were measuring serum creatinine level, creatinine clearance and blood urea nitrogen (BUN) before PCI and (2-3) days after procedure. Results: In Group A, nonsignificant reduction of serum creatinine level (P: 0.90), creatinine clearance (P: 40) but significant reduction BUN was seen after treatment (P: 0.017). In Group B, Significant reduction of serum creatinine level, and BUN (P< 0.001).  But creatinine clearance not significant changes were seen after treatment (P:0.72). On other hand comparison between two group was significant reduction of serum creatinine level (P: 0.046) in group B, but creatinine clearance and BUN were not significant (0.41, 0.34) respectively. Conclusion: High dose rosuvastatin plus N-acetylcysteine compared rosuvastatin had significant reduction only of creatinine level without reduction in BUN and creatinine clearance among patients undergoing PCI.
Comparison of Syntax II Score And Grace Score As Predictors of Major Cardiovascular Events 30 Days after Treatment in STEMI Undergoing PPCI Abimanyu, Roni; Sitepu, Andika; Nasution, Ali Nafiah
Journal of Society Medicine Vol. 3 No. 6 (2024): June
Publisher : CoinReads Media Prima

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.47353/jsocmed.v3i6.150

Abstract

Introduction: IMA-EST is still the main cause of morbidity and mortality in Coronary Artery Disease (CAD) and PPCI is still the main treatment method for IMA-EST patients. Even though PPCI has been undergone, patients are reported to still experience mortality and morbidity both in hospital and after discharged. The SYNTAX II score uses clinical, laboratory and anatomical parameters that are believed to be better than the GRACE score to predict mortality and morbidity. Method: This study is an observational analytic with a retrospective cohort design in STEMI patients who underwent PPCI at HAM General Hospital from January 2023 to June 2023. Patients who were diagnosed with STEMI and underwent with PPCI had their GRACE score and SYNTAX II score calculated and followed for 30 days. SYNTAX-II Score’s cut-off point, sensitivity and specificity as well as predictive possibilities in predicting adverse outcomes were determined. Then bivariate analysis was carried out on each SYNTAX-II Score and GRACE score. Results: The study subjects totaled 73 people with an average age of 56.05 ± 10.07 years. The incidence of MACE 30 days after treatment in our sample was 23.3%. It was found that the SYNTAX II score could well predict occurrence of MACE 30 days after treatment (cut off 33,75, AUC 0.861; 0.773 – 0.949; sensitivity 94.1%; specificity 69.6%, PPV 94.1% and NPV 67.6). The result of the bivariate analysis of the SYNTAX-II Score were: P < 0,0001; OR: 18,353; 95%; CI: 2,566 – 131,241and the results of the GRACE Score were: P < 0,006; OR 5,854; 95%; CI: 1,442 – 23,764. Conclusion: The SYNTAX II score is better to predict occurrence of MACE 30 days after treatment in STEMI patients who  undergoing PPCI compared to the GRACE score.
Differences in MPV (Mean Platelet Volume) / Lymphocytes Ratio In Chronic Hepatitis B with and without Cirrhosis Hepatic Elsha, Elsha Sinulingga; Siregar, Jelita; Sungkar, Taufik
Journal of Society Medicine Vol. 3 No. 6 (2024): June
Publisher : CoinReads Media Prima

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.47353/jsocmed.v3i6.151

Abstract

Introduction: The MPV/Lymphocyte Ratio is a simple inflammatory parameter that can be obtained from a complete blood count. Hepatitis patients with liver cirrhosis have a higher MPV causing thrombopoietin to decrease so that the platelet count decreases. The inflammatory response can cause a decrease in the number of lymphocytes and is closely related to a poor prognosis in patients with hepatitis B virus. This study aims to examine the differences in the MPV/Lymphocyte ratio in chronic hepatitis B patients with and without liver cirrhosis. Methods: The samples for this study was chronic hepatitis B patients with and without liver cirrhosis who met he inclusion criteria. The research was carried out by taking blood samples from 94 patients treated in the internal medicine treatment room and Gastroenterohepatology polyclinic at Adam Malik Hospital, Medan. Samples were examined for MPV, absolute lymphocytes, then the MPV/lymphocyte ratio was calculated. Results: The total number of subjects in this study was 94 and there were 62 men and 32 women. The results of the analysis showed that there was a significant difference between the cirrhotic and non-cirrhotic groups (p = 0.001). Conclusion: There was a significant difference in the ratio of MPV/lymphocytes in the group of hepatitis B subjects with cirrhosis and in the group of hepatitis B subjects without liver cirrhosis. (p = 0.001).
Literature Review for Iliaca, Scapula, and Fibula Free Flap as A Modality in Mandibular Ameloblastoma Reconstruction Tillasman, Natassya Sandra; Laksmi, Putu Pradnyasanti; Roosseno, Ratna Rayeni Natasha; Hamid, Agus Roy Rusly Hariantana
Journal of Society Medicine Vol. 3 No. 6 (2024): June
Publisher : CoinReads Media Prima

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.47353/jsocmed.v3i6.152

Abstract

Introduction: Mandibular reconstruction is complex as there are multiple goals for the final outcome, with a main focus of returning form and function as close to baseline as possible. It may be challenging for ameloblastoma treatment which is focused on surgical resection with a wide margin of normal tissue because of its high propensity for regional invasion. Free vascularized bone flaps are widely recognized as the optimal reconstruction for this case and have been widely developed from the iliaca, scapula, or fibula. Methods: Using the PubMed and Google Scholar databases, we searched for reported cases of ameloblastoma published in the English-language literature. Results: We were able to retrieve 47 acceptable literatures and perform a comprehensive literature review, particularly those using microvascular composite free flaps, then compared iliaca, scapula, and fibula free flaps to identify optimal flap choice for mandibular reconstruction. In addition, we present an additional case of ameloblastoma affecting the anterior mandible in a 26-year-old male patient. Conclusion: Microsurgical techniques are now considered safe and reliable in reconstruction of the jaws by reestablishing the continuity and normal anatomy, aiding to restore the normal function of swallowing, mastication, and speech production. In our experience, free osteocutaneous fibula flap technique is a further confirmation of its potential in the reconstruction of hard and soft tissue in maxillofacial surgery.

Page 1 of 1 | Total Record : 5

 1 

Filter by Year

2024 2024


Reset
Filter By Issues
All Issue Vol. 4 No. 12 (2025): December Vol. 4 No. 11 (2025): November Vol. 4 No. 10 (2025): October Vol. 4 No. 9 (2025): September Vol. 4 No. 8 (2025): August Vol. 4 No. 7 (2025): July Vol. 4 No. 6 (2025): June Vol. 4 No. 5 (2025): May Vol. 4 No. 4 (2025): April Vol. 4 No. 3 (2025): March Vol. 4 No. 2 (2025): February Vol. 4 No. 1 (2025): January Vol. 3 No. 12 (2024): December Vol. 3 No. 11 (2024): November Vol. 3 No. 10 (2024): Oktober Vol. 3 No. 9 (2024): September Vol. 3 No. 8 (2024): August Vol. 3 No. 7 (2024): July Vol. 3 No. 6 (2024): June Vol. 3 No. 5 (2024): May Vol. 3 No. 4 (2024): April Vol. 3 No. 3 (2024): March Vol. 3 No. 2 (2024): February Vol. 3 No. 1 (2024): January Vol. 2 No. 12 (2023): December Vol. 2 No. 11 (2023): November Vol. 2 No. 10 (2023): October Vol. 2 No. 9 (2023): September Vol. 2 No. 8 (2023): August Vol. 2 No. 7 (2023): July Vol. 2 No. 6 (2023): June Vol. 2 No. 5 (2023): May Vol. 2 No. 4 (2023): April Vol. 2 No. 3 (2023): March Vol. 2 No. 2 (2023): February Vol. 2 No. 1 (2023): January Vol. 1 No. 3 (2022): December Vol. 1 No. 2 (2022): November Vol. 1 No. 1 (2022): October More Issue